Leading edge maintenance in migrating cells is an emergent property of branched actin network growth
Abstract
Animal cell migration is predominantly driven by the coordinated, yet stochastic, polymerization of thousands of nanometer-scale actin filaments across micron-scale cell leading edges. It remains unclear how such inherently noisy processes generate robust cellular behavior. We employed high-speed imaging of migrating neutrophil-like HL-60 cells to explore the fine-scale shape fluctuations that emerge and relax throughout the process of leading edge maintenance. We then developed a minimal stochastic model of the leading edge that reproduces this stable relaxation behavior. Remarkably, we find lamellipodial stability naturally emerges from the interplay between branched actin network growth and leading edge shape - with no additional feedback required - based on a synergy between membrane-proximal branching and lateral spreading of filaments. These results thus demonstrate a novel biological noise-suppression mechanism based entirely on system geometry. Furthermore, our model suggests that the Arp2/3-mediated ~70‑80º branching angle optimally smooths lamellipodial shape, addressing its long-mysterious conservation from protists to mammals.
Data availability
Analysis and modeling code for this paper is available on the Theriot lab Gitlab:<https://gitlab.com/theriot_lab/leading-edge-stability-in-motile-cells-is-an-emergent-property-of-branched-actin-network-growth> under the MIT license. Figure data are available in the Source Data files. The large size of the raw video microscopy data (865 GB of image files in the Open Microscopy Environment OME-TIFF format) and the associated analyzed data (320 GB) prohibits their upload to a public repository. The complete raw and analyzed data files for one example experimental dataset and one example simulated dataset (corresponding to the data shown in Fig. 1a-f and Fig. 2c-j, respectively) are available on Figshare <https://figshare.com/projects/Leading_edge_stability_in_motile_cells_is_an_emergent_property_of_branched_actin_network_growth/132878>. Code to analyze this data are publicly available on Gitlab as noted above. Requests for additional raw or analyzed data should be sent to the corresponding author by email. Data will be made available in the form of a hard drive shipped by mail. There are no restrictions on who may access the data.
Article and author information
Author details
Funding
National Science Foundation
- Rikki M Garner
Howard Hughes Medical Institute
- Julie A Theriot
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: Experiments using zebrafish larvae were approved by the University of Washington Institutional Animal Care and Use Committee (protocol 4427-01).
Copyright
© 2022, Garner & Theriot
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Cell Biology
Niemann–Pick disease type C (NPC) is a devastating lysosomal storage disease characterized by abnormal cholesterol accumulation in lysosomes. Currently, there is no treatment for NPC. Transcription factor EB (TFEB), a member of the microphthalmia transcription factors (MiTF), has emerged as a master regulator of lysosomal function and promoted the clearance of substrates stored in cells. However, it is not known whether TFEB plays a role in cholesterol clearance in NPC disease. Here, we show that transgenic overexpression of TFEB, but not TFE3 (another member of MiTF family) facilitates cholesterol clearance in various NPC1 cell models. Pharmacological activation of TFEB by sulforaphane (SFN), a previously identified natural small-molecule TFEB agonist by us, can dramatically ameliorate cholesterol accumulation in human and mouse NPC1 cell models. In NPC1 cells, SFN induces TFEB nuclear translocation via a ROS-Ca2+-calcineurin-dependent but MTOR-independent pathway and upregulates the expression of TFEB-downstream genes, promoting lysosomal exocytosis and biogenesis. While genetic inhibition of TFEB abolishes the cholesterol clearance and exocytosis effect by SFN. In the NPC1 mouse model, SFN dephosphorylates/activates TFEB in the brain and exhibits potent efficacy of rescuing the loss of Purkinje cells and body weight. Hence, pharmacological upregulating lysosome machinery via targeting TFEB represents a promising approach to treat NPC and related lysosomal storage diseases, and provides the possibility of TFEB agonists, that is, SFN as potential NPC therapeutic candidates.
-
- Cell Biology
- Developmental Biology
A study in mice reveals key interactions between proteins involved in fibroblast growth factor signaling and how they contribute to distinct stages of eye lens development.